APP and Alzheimer disease: However, transgenic mice overexpressing APP, with a single or multiple amyloidogenic mutant human genes, have mutations not present in the human sporadic form of AD, and the temporal progression of the disease in mice does not correlate well with AD in humans (Masurkar and Devanand, 2014).